Document is current
Any future updates will be listed below
-
Authors
Sarhadi, Kamron
Hamman, Justin
Avila, Jorge
Jian, Zhongping
Fleming, Neal W.
- License Information
-
More Information
Article History
Received: 9 January 2025
Accepted: 18 April 2025
First Online: 29 April 2025
Declarations
:
: The study was approved by the UC Davis Institutional Review Board (IRB #1791102-1) and registered on ClinicalTrials.gov (NCT05025176) before the enrollment of the first patient. All study related procedures were performed in accordance with relevant guidelines and regulations. All patients provided written informed consent prior to enrollment.
: Not applicable.
: Kamron Sarhadi, MD: No competing interests. Justin Hamman, MD: No competing interests. Jorge Avila, MD: No competing interests. Zhongping Jian, PhD: Is an employee of Edwards LifeSciences Critical CareNeal W Fleming, MD, PhD: Has received support for contracted research from Acacia Pharma, Tsumera Pharmaceuticals, Haisco Pharmaceuticals, Masimo, Inc., Rostrum Medical Innovations and Edwards LifeSciences and received honoraria from Edwards LifeSciences for invited presentations.
